We describe several yeast nuclear mutations that specifically block expression of the mitochondrial genes encoding cytochrome c oxidase subunits II (C O X II) and III (C O X III). These recessive mutations define positive regulators of mitochondrial gene expression that act at the level of translation. M utations in the nuclear gene P E T \ \ \ completely block accumulation of C O X II, but the C O X II mRNA is present in m utant cells at a level approximately one-third of that of the wild type. M itochondrial suppressors o f petiW mutations correspond to deletions in mtDNA that result in fusions between the cox\\ structural gene and other mitochondrial genes. The chimeric mRNAs encoded by these fusions are translated in m utants; this translation leads to accumulation of functional C O X II. The PET111 protein probably acts directly on c o xI I translation, because it is located in mitochond Translation of the mitochondrially coded mRNA for C O X III requires the action of at least three nuclear genes, PE'7'494, and a newly discovered gene, provisionally termed PET55. Both the PET494 and PET54 proteins are located in mitochondria and therefore probably act directly on the mitochondrial translation system. M utations in all three genes are suppressed in strains that contain chimeric coxlW mRNAs with the 5'-untranslated leaders of other mitochondrial transcripts fused to the cox III coding sequence. The products of all three nuclear genes may form a complex and carry out a single function. A direct demonstration that the wild-type nuclear gene products act in the coxlW 5'-leader has been obtained by showing that they are all required for translation of apocytochrome b from a novel mRNA consisting of the coxlYl 5'-leader attached to the cytochrome b coding sequence. The site (or sites) of action maps at least 172 bases upstream from the coxlll initiation codon in the 600 base cox III leader. Others have reported evidence which sugge that coxYll translation is repressed by glucose. Consistently with the possibility that the nuclear genes described here may play a role in modulating mitochondrial gene expression, we have found that PET494 expression is glucose-repressed.
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Introduction
In all eukaryotes, the abundance of mitochondrial gene products must be maintained at levels in balance with those of the nuclear gene products that are their partners in enzyme complexes. In addition, in facultative anaerobes like the yeast Saccharomyces cerevisiae, the levels of mitochondrial gene products must change in response to changes in environmental conditions, such as the level of glucose. The mechanisms by which mitochondrial gene expression is regulated are very poorly understood, but probably include controls at the levels of transcription, mRNA processing, translation and protein stability. By studying mutants of yeast that are defective in the expression of specific mitochondrial genes, we hope to obtain a better understanding of these molecular mechanisms.
T. D. F O X AND OTHERS
Among collections of yeast strains that are respiratory-deficient owing to nuclear mutations, a surprisingly large number of mutants have functional mitochondrial genetic systems but are defective in the expression oi specific mitochondrial genes (Michaelis al. 198 1986 a; McEwen et al. 1986) . Such mutations are of particular interest because it is likely that they define im portant regulatory genes that govern expression of the mitochondrial genome. We have chosen to concentrate our Effort on the study of nuclear genes required for expression of the mitochondrial genes coding cytochrome c oxidase subunits II (C O X II) and III (C O X III). (These genes are known formally as oxil and respectively, but will be referred to here as the c o xI I gene and the cox III gene.) All the nuclear mutations examined so far that affect expression of II and III are recessive and are blocked in gene expression post-transcriptionally. In several cases, discussed here, we have shown that the wild-type nuclear genes are required to activate translation of the mitochondrially coded mRNAs. The requirements for specific translational activation can be surprisingly complex: in coxIII at least three nuclear genes must act at a site or sites in the 5 -untranslated leader of the mitochondrially coded mRNA. Here we summarize our findings on the control of mitochondrial translation by nuclear genes, and discuss them in light of studies, by others, on changes in mitochondrial gene expression in response to glucose levels.
C O X I I TRANSLATION REQUIRES THE PRODUCT OF NUCLEAR GENE
The synthesis of yeast mitochondrial translation products can be easily studied vivo by radioactively pulse-labelling cells in the presence of cycloheximide, separating the proteins by SDS-gel electrophoresis and radioautographing the gels. Strains with mutations in the nuclear gene P E T 111 (formerly P E T li (Ebner et al. 1973) ) carried out mitochondrial gene expression normally, as judged by such labelling experiments, except that they specifically failed to accumulate C O X II (Cabral & Schatz 1978; Poutre & Fox 1987 ) (figure 1). In addition, C O X II was undetectable in petW i mutants by immunological assays of unla that easily detected C O X II at one hundredth of the wild-type level (Poutre & Fox 1987) . Despite the absence of the C O X II protein in petl 11 muta Figure 1 . COXII does not accumulate in a pett 11 mutant, but the coxll mRNA is present, (a) Mitochondrial translation products were visualized by radioactive labelling, in the presence of cycloheximide, followed by SDS-gel electrophoresis and radioautography. The position of COXII is indicated. Lane A, wild type; lane B, an isogenic pet\ 11 mutant, (b) Total RNA was isolated from cells, subjected to electrophoresis, blo hybridized to a probe specific for the c o xI I mRNA. The filter was radioautogra mRNA is indicated. (Lanes A, B as in (a).) mRNA was easily detectable in m utant cells, although its steady-state level was reduced by approximately three times relative to that of the wild type (Poutre & Fox 1987) (figure 1). Because the reduction in the level of c o xI I mRNA inmutants is far t for the absence of the protein, we conclude that the nuclear m utation blocks a posttranscriptional step in c o xI I expression. The data are most easily explained by the hypo that P E T 111 function is required for translation of the mRNA and that, in the absence of translation (in a. p e tlll m utant) the c o xI I mRNA in a lower mRNA steady-state level.
This hypothesis is strongly supported by the fact that it has been possible to isolate mitochondrial mutations that suppress p e tlll nuclear mutations, dem can be stably incorporated into active cytochrome oxidase in the absence of 111 function, if the translational defect is bypassed. These suppressors, termed correspond to deletions in ; mtDNA that result in fusions between the II structural gene and other mitochondrial genes (Poutre & Fox 1987) . The 11 -coded II mRNAs were thus substituted for the normal S'-untranslated leader and translation initiation codon. The rearranged c o xI I genes were carried on p~ mtDNA molecules of the kind normally found in 'cytoplasmically petite' yeast strains. However, under selective conditions, these p~ mtDNAs were maintained heteroplasmically with wild-type mtDNA. Despite the fact that the 111 suppressors encoded variants of C O X II 50-70 amino acids longer than those of the wild type at the N-terminal end, MSU1 11 -suppressed mutants accumulated wild-type C O X II (Poutre & Fox 1987) . Because C O X II is normally made as a precursor with a 15 amino acid N-terminal extension (Pratje etal. 1983) , and becau proteins encoded by M SU i l l suppressors contained the processing site, the chimeric p must have been processed to yield wild-type C O X II. These findings suggest that, in the wild type, the product of P E T 111 (or something under its control) acts at a site coded proximal part of the c o xI I gene. This site of action may lie in the mRNA, as in nuclear products controlling coxlW translation (see below). However, other models (Poutre & Fox 1987) in which the product of PET111 interacts with the C O X II precu cannot be excluded, because the M SU 111 suppressors that have been isolat the c o xI I mRNA and the precursor protein. We have isolated the P E T 111 gene (Poutre & Fox 1987) , determined its nucleotide (Strick & Fox 1987) and generated antibodies to the polypeptide it encodes (unpublished results). As a first step towards understanding the mechanism by which the 111 gene product acts we have determined its intracellular location. The PET111 protein was shown to be mitochondrially located by two lines of experimentation. First, expression in yeast of a p e tlll ::lacZ fusion gene encoding a protein with the N-terminal 154 amino acids of PET111 attached to (3-galactosidase resulted in mitochondrial localization of (3-galactosidase activity (Strick & Fox 1987) . Second, direct immunological detection of the PET111 protein in subcellular fractions from a yeast strain in which PET111 was overproduced confirmed that it was located in mitochondria (unpublished results). We therefore conclude that the PET111 protein acts directly to promote c o xI I translation rather than indirectly activating another nuclear gene.
The poly (A) mRNA copied from PET111 has an unusual structure (Strick & Fox 1987 ). The 5'-untranslated leader is 470 nucleotides long and contains four short open reading frames that exhibit an interesting pattern of overlap with each other and with the PET111 structural gene. We have not yet examined the regulation of P E T 1 11. However, another yeast regulatory gene, GC7V4, which also has a long 5'-leader containing short open reading frames, is regulated at the level of translation (Hinnebusch 1984 ). It will be interesting to explore the possibility that PET111, a specific activator of c o xI I translation, may itsel We have continued to search among our collection of mutants for strains unable to express coxII owing to mutations in genes other than P E T l l l . One strain, with a phenotype very similar to that p e tlll mutants, carries a mutation in a new gene, termed 112. The mutation complements p e tlll and is unlinked to it (unpublished results). Likep e tlll mutants, the p etll2 m utant lacks C O X II, as judged both by pulse-labelling experiments and immunoassay of steady-state protein levels. Moreover, the m utant contains the coxYl mRNA at a level reduced somewhat relative to that of the wild type. However, the m utant is phenotypically distinguishable from/>r/l 11 in that it accumulates a novel unidentified mitochondrial translation product that is immunologically unrelated to C O X II. More importantly, the p etll2 mutation is not suppressed by the 111 mitochondrial sup described above. Thus, either PET112 is required for a step in II e later than the PET111 step, or PET112 is required for other mitochondrial functions in addition to promoting translation of c o xI I.
A ctivation of COXIII translation by three nuclear gene products M utations in the nuclear genes Pis 7*494 (Ebner et al. 1973 ; Cabral & Schatz 1978; , PET54 ) and a newly identified gene, provisionally termed Pis 7*55, all block accumulation of the mitochondrial gene product C O X III (figure 2). jta/494, pet54 and pet55 mutations complement each other and are genetically unlinked. M utants in the same three complementation groups have also been isolated by others (McEwen et al. 1986 ; J. E. McEwen, personal communication; unpublished results).
Although mutations in any one of these three genes block C O X III accumulation, none of the mutations affects the steady-state level of coxlll mRNA b)(figure 3). Unlike the mutants blocked in coxYl translation described above, whose coxII mRNA levels were reduced relative to those of the wild type, and mutations have no measurable effect on the cox III mRNA. Because th the wild-type genes must be positive activators of a post-transcriptional step in III gene expression.
cox III► Figure 3 . The cox III mRNA is present at wild-type levels in and mutants. Total RNA was isolated from various strains, subjected to electrophoresis, blotted and hybridized to both a probe specific for the coxIII mRNA (a) and a probe specific for the mitochondrial 155 rRNA ( as a control for quantitation. The phenotypes of pet494, pet54 and mechanisms of action. Either the wild-type gene products could be required to activate translation of the cox III mRNA, or they could be required to stabilize the C O X III protein after synthesis to prevent its rapid degradation. T h at mutations block translation of the cox III mRNA was demonstrated by isolating and examining mitochondrial mutations that suppressed a pet494 deletion m utation ). These mitochondrial suppressors, termed MSU494, were the result of deletions in mtDNA that fused the 5'-flankin sequences of the roxIII structural gene to the 5'-flanking regions of other mitochondrial genes without altering the coxYll coding sequence, as illustrated schematically in figure 4. Transcription of the chimeric genes generated novel III mRNAs with the 5'-untranslated leaders of other mitochondrial transcripts attached to the wild-type III structural gene (figure 3). These chimeric mRNAs, with 5'-leader substitutions, were translated (in cells heteroplasmic for the MSU494 and wild-type mitochondrial genomes) to yield wild-C O X III protein that accumulated and functioned in m utant cells . Interestingly, the defects in C O X III accumulation of both pet54 and p e t 55 (unpublished results) mutations were also suppressed in cells containing the MSt/494-encoded chimeric coxIII mRNAs. Thus, PET494, and PET55 are all required to activate translation of the mitochondrially coded III mRNA. Furthermore, the observation of co-suppression suggests the possibility that the products of all three nuclear genes act together to carry out a single function. We have isolated the PET494 and PE T generated antibodies to the polypeptides they encode Costanzo 1986a; unpublished results) . Direct immunological detection of the PET494 protein in subcellular fractions from a yeast strain in which PET494 was overproduced revealed that PET494 co-purified specifically with mitochondria . Similar experiments with an anti-PET54 anti-serum that allowed detection of PET54 in fractions from wild-type (non-overproducing) yeast cells demonstrated that the PET54 protein was also specifically located in mitochondria (unpublished data). Thus both of these nuclearly coded proteins must act directly in the organelles to promote III translation. The subcellular location of the PE T55 gene product is currently unknown, leaving open the possibility that it acts indirectly. For example, one plausible explanation for the phenotype of pet55 mutants would be that they are defective in expression of a n d /o r However, we have found that pet55 mutants express both PET494 (unpublished results), ruling out this particular hypothesis. We therefore consider it probable that, like the PET494 and PET54 proteins, the PET55 gene product also acts directly in mitochondria to promote coxlYl translation. The analysis of mitochondrial mutations that suppressed and mutations suggested that the wild-type nuclear gene products act at a site (or sites) in the 5'-untranslated leader of the cox III mRNA. We have recently obtained direct evidence that this is the cas showing that all three wild-type nuclear genes are required for translation of apocytochrome b from a novel chimeric mRNA consisting of part of the III mRNA 5'-leader attached to the cytochrome b coding sequence. To obtain a chimeric mitochondrial gene encoding such an mRNA, we isolated mitochondrial suppressors of the nuclear m utation 1, which specifically blocks translation of the cob mRNA encoding cytochrome b (Rodel et al. 1985) . One of 70 cbs\ suppressor genes isolated carried the region encoding the 5' two-thirds of the III mRNA leader fused to the cob structural gene (unpublished results).
To study translation of this chimeric mRNA, synthesis of cytochrome b was monitored in zygotes whose mitochondria contained both a wild-type genome and the chimeric gene. The zygotes were also homozygous for the cbsl m utation, and therefore could not translate the wild-type cob mRNA. Zygotes that were wild-type for PE T54 and PE T55 synthesized cytochrome b. However, homozygous , pet54 or mutations specifically blocked synthesis of cytochrome b in the zygotes (unpublished results). Thus, all three nuclear gene products were required to activate translation of this chimeric mRNA by acting at a site or sites in the cox III 5'-untranslated leader. Furtherm ore, because the chimeric mRNA lacks the 3' 172 bases of the cox\\\ untranslated leader, we conclude that the target (or targets) these nuclear gene products must lie at least 172 nucleotides upstream of the AUG initiation codon in the wild-type cox III mRNA. The nuclear genes required specifically to activate III translation could play a role in m odulating cox III gene expression. If this were the case, one might expect to find that conditions known to lower C O X III levels, such as glucose repression (Falcone et 1983) , also lead to lower levels of expression of the nuclear genes. We have studied the effect of glucose on PE T494 expression in a respiring diploid strain in which one chromosomal copy ofPZs7T94 was replaced by a p e t 4 9 4 : : l a c Zf usion. The specific activity of P-galactosidase was approximately fivefold higher in cells grown on medium containing ethanol as a carbon source than in cells grown on medium containing glucose (unpublished results). Addition of glucose to ethanol-glycerol medium repressed P-galactosidase activity. Thus, expression is controlled in a manner consistent with its possible role in modulating expression of the mitochondrial gene for C O X III. Interestingly, expression of the fusion was unaffected by mutations controlling glucose repression of the enzyme invertase (Neigeborn & Carlson 1984; T. D. Fox et al., unpublished results) ; this result indicates that multiple systems may control glucose repression in yeast.
D iscussion
Translation of the mitochondrially coded cox III mRNA is depe nuclear genes PET494, PET54 and PET55. Although the molecular mec cox\\\ translation is stimulated remains unknown, we have demonstrated that the PET494 and PET54 proteins are located in mitochondria and that a site of action for all three nuclear genes can be mapped genetically to a region of the 600 base 5'-untranslated leader of the III mRNA, at least 172 bases upstream of the translation initiation codon. The results are thus consistent with a model (figure 5) in which the three nuclear genes encode subunits of a complex that functions in mitochondria as a cox\Y\ mRNA-specific translation initiation factor. It remains to be determined whether the PET55 gene product is a mitochondrial protein, as well as whether the products of all three genes directly interact with each other and with the III mRNA.
As mentioned above, we are unable to distinguish whether the mitochondrially located PET111 protein functions by interacting with the mitochondrially coded II mRNA or with the C O X II precursor protein, owing to the fact that the MSU111 suppressors alter both. However, because it is clear that P E T 111 acts post-transcriptionally and that it is not required for the stability or function of the m ature C O X II protein, our working hypothesis is that PET111 activates c o xI I translation. The mechanism of action of PET112 in promoting C O X II accumulation is even less well understood since the mutation is not suppressed by the MSU111 suppressors.
In addition to C O X II and C O X III, the expression of the mitochondrial gene product apocytochrome b is known to be under translational control. Translation of the cob mRNA encoding cytochrome b requires the action of at least three nuclear genes (Dieckmann & Rodel et al. 1985; Rodel 1986) . One of these genes, 1, to have a site of action in the 5'-untranslated leader of the cob mRNA (Rodel & Fox 1986 ) and may therefore act by a mechanism similar to that of the genes controlling C O X III.
Frontali and co-workers have reported that, although the synthesis of all mitochondrial translation products increased after the release of glucose repression (Falcone 1983) , the behaviour of their mitochondrially coded mRNAs varied (Zennaro et al. 1985) . For example, the steady-state level of the cox III mRNA did not change detectably, whe coxII mRNA increased after release of glucose repression. One could interpret these data as indicating that some mitochondrial genes are controlled transcriptionally (roxll), whereas others are not (coxlll). However, these data are also consistent with a model in which transcription of both genes is constitutive and C O X II and C O X III synthesis is controlled at the level of translation. One must simply assume that absence of translation decreases the stability of some mRNAs but not others. Indeed, our data on the levels of II and coxlll mRNAS in nuclear mutants specifically blocked in their translation strongly suggests that the coxII mRNA is less stable in the absence of translation and the stability of the coxlll mRNA is unaffected by translation. Thus, presently available data are consistent with the notion that modulation of mitochondrial gene expression in yeast occurs largely at the level of translation. It will be of great interest to determine whether any of the nuclear genes described here play a role in this modulation.
